- Home
- KROS vs RBBN Comparison
KROS vs RBBN Comparison
Compare KROS & RBBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KROS
- RBBN
- Stock Information
- Founded
- KROS 2015
- RBBN 1997
- Country
- KROS United States
- RBBN United States
- Employees
- KROS N/A
- RBBN N/A
- Industry
- KROS Biotechnology: Pharmaceutical Preparations
- RBBN EDP Services
- Sector
- KROS Health Care
- RBBN Technology
- Exchange
- KROS Nasdaq
- RBBN Nasdaq
- Market Cap
- KROS 565.0M
- RBBN 671.1M
- IPO Year
- KROS 2020
- RBBN 2000
- Fundamental
- Price
- KROS $15.65
- RBBN $3.95
- Analyst Decision
- KROS Buy
- RBBN Strong Buy
- Analyst Count
- KROS 14
- RBBN 4
- Target Price
- KROS $20.56
- RBBN $6.00
- AVG Volume (30 Days)
- KROS 445.6K
- RBBN 543.5K
- Earning Date
- KROS 11-05-2025
- RBBN 10-22-2025
- Dividend Yield
- KROS N/A
- RBBN N/A
- EPS Growth
- KROS N/A
- RBBN N/A
- EPS
- KROS 0.47
- RBBN N/A
- Revenue
- KROS $232,844,000.00
- RBBN $863,459,000.00
- Revenue This Year
- KROS $5,579.44
- RBBN $7.26
- Revenue Next Year
- KROS N/A
- RBBN $5.52
- P/E Ratio
- KROS $33.59
- RBBN N/A
- Revenue Growth
- KROS 85820.30
- RBBN 7.68
- 52 Week Low
- KROS $9.12
- RBBN $2.84
- 52 Week High
- KROS $72.37
- RBBN $5.38
- Technical
- Relative Strength Index (RSI)
- KROS 59.98
- RBBN 49.41
- Support Level
- KROS $15.25
- RBBN $3.97
- Resistance Level
- KROS $16.00
- RBBN $4.24
- Average True Range (ATR)
- KROS 0.61
- RBBN 0.15
- MACD
- KROS 0.03
- RBBN 0.00
- Stochastic Oscillator
- KROS 78.77
- RBBN 48.21
About KROS Keros Therapeutics Inc.
Keros Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from hematological, pulmonary, and cardiovascular disorders with high unmet medical needs. The company's protein therapeutic product candidate, KER-050, is being developed for the treatment of low blood cells counts, or cytopenias, including anemia and thrombocytopenia, in patients with myelodysplastic syndromes, or MDS, and in patients with myelofibrosis.
About RBBN Ribbon Communications Inc.
Ribbon Communications Inc provides network solutions to service providers and enterprises. The company enables service providers and enterprises to modernize their communications networks and provide secure real-time communications solutions to their customers and employees. The company has two separate lines of business; the Cloud and Edge segment, and the IP Optical Networks segment. The majority of the revenue for the company is generated from its Cloud and Edge segment that provides secure and reliable software and hardware products, solutions, and services for VoIP communications, Voice Over LTE among others to service providers and enterprise customers. The company generates majority of its revenue from United States.